Literature DB >> 19673653

Influenza vaccine manufacture: keeping up with change.

Kathleen M Neuzil, Rick A Bright.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19673653     DOI： 10.1086/605507

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Cell culture-derived flu vaccine: Present and future.

Authors:  Alberto Pérez Rubio; Jose María Eiros
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

Review 2.  Plant-made vaccines in support of the Millennium Development Goals.

Authors:  Claire A Penney; David R Thomas; Sadia S Deen; Amanda M Walmsley
Journal:  Plant Cell Rep       Date:  2011-01-18       Impact factor: 4.570

3.  Influenza emergence in the face of evolutionary constraints.

Authors:  Adam Kucharski; Julia R Gog
Journal:  Proc Biol Sci       Date:  2011-07-20       Impact factor: 5.349

Review 4.  Emerging, novel, and known influenza virus infections in humans.

Authors:  Julian W Tang; Nandini Shetty; Tommy T Y Lam; K L Ellis Hon
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

5.  Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.

Authors:  S G Sullivan; K S Carville; M Chilver; J E Fielding; K A Grant; H Kelly; A Levy; N P Stocks; S S Tempone; A K Regan
Journal:  Epidemiol Infect       Date:  2016-04-29       Impact factor: 4.434

6.  Las vacunas de la gripe basadas en las partículas virus-like obtenidas mediante sistemas de expresión génica en células de insectos.

Authors:  J Reina
Journal:  Vacunas       Date:  2012-11-23

Review 7.  Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.

Authors:  Cole J Batty; Mark T Heise; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Drug Deliv Rev       Date:  2020-12-13       Impact factor: 17.873
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.